Trimingham Claire, McDonald Stephen, Dansie Kathryn, Jesudason Shilpa, Faull Randall, Clayton Phil, Liew Grace, Le Leu Richard, Meade Anthony
Central and Northern Adelaide Renal and Transplantation Service, Royal Adelaide Hospital, Adelaide, Australia.
ANZDATA, South Australian Health and Medical Research Institute, Adelaide, South Australia.
J Ren Care. 2018 Jun;44(2):65-72. doi: 10.1111/jorc.12230. Epub 2018 Jan 8.
The bowel health of those with chronic kidney disease (CKD) can be affected by medications, fluid/dietary allowances, reduced activity and pre-existing medical conditions. Patient perceptions of their bowel health can differ from those of health care professionals and the burden of gastrointestinal symptoms could be inaccurately reported.
Adults with CKD, including those undergoing haemodialysis, peritoneal dialysis and kidney transplant from four South Australian hospitals enrolled in the study. Participants completed a five-item questionnaire, to investigate their perception of bowel health compared with clinical criteria for 'normal and abnormal' bowel health using the Bristol Stool Form Scale, bowel frequency and reported symptoms.
A total of 324 individuals completed the questionnaire. Of those with clinically defined 'abnormal' bowel health (n = 180), 50.6% perceived their bowels as 'normal' or 'more normal than abnormal'. Only 6% of this clinically 'abnormal' group perceived their bowel health as abnormal. Of those with clinically defined 'normal' bowel health (n = 144), 16% perceived their bowel health as 'abnormal', 'more abnormal than normal' or 'variable'. Fifty-seven percent of patients with clinically defined 'abnormal' bowel health were not taking any treatments. Peritoneal dialysis recipients were the highest users of treatments to improve bowel function, with 62% using 1 or more treatment.
It is common for patients with CKD to experience signs and symptoms of abnormal bowel health. There is a disconnect between patient perceptions and clinical definitions of normal or abnormal bowel health. Clinical care team members must carefully obtain and clarify patient-reported symptoms related to bowel function in order to help ensure recommendations and use of appropriate treatments.
慢性肾脏病(CKD)患者的肠道健康可能受到药物、液体/饮食限制、活动减少及既往病史的影响。患者对自身肠道健康的认知可能与医护人员不同,胃肠道症状的负担可能未得到准确报告。
来自南澳大利亚四家医院的成年CKD患者,包括接受血液透析、腹膜透析和肾移植的患者参与了该研究。参与者完成了一份包含五个项目的问卷,以使用布里斯托大便分类法、排便频率和报告的症状,调查他们与“正常和异常”肠道健康临床标准相比对肠道健康的认知。
共有324人完成了问卷。在临床定义为“异常”肠道健康的患者(n = 180)中,50.6%认为自己的肠道“正常”或“比异常更正常”。在这个临床“异常”组中,只有6%的人认为自己的肠道健康异常。在临床定义为“正常”肠道健康的患者(n = 144)中,16%认为自己的肠道健康“异常”、“比正常更异常”或“不稳定”。临床定义为“异常”肠道健康的患者中有57%未接受任何治疗。腹膜透析接受者是改善肠道功能治疗的最高使用者,62%使用了1种或更多治疗。
CKD患者出现肠道健康异常的体征和症状很常见。患者对正常或异常肠道健康的认知与临床定义之间存在脱节。临床护理团队成员必须仔细获取并澄清患者报告的与肠道功能相关的症状,以帮助确保推荐和使用适当的治疗方法。